Skip to main content

Peer Review reports

From: The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis

Original Submission
30 Nov 2018 Submitted Original manuscript
6 Jan 2019 Reviewed Reviewer Report - Aung Naing
20 Jan 2019 Reviewed Reviewer Report - Pablo Fernández Peñas
13 Feb 2019 Author responded Author comments - Lihu Gu
Resubmission - Version 2
13 Feb 2019 Submitted Manuscript version 2
10 Apr 2019 Reviewed Reviewer Report - Aung Naing
22 Apr 2019 Reviewed Reviewer Report - Pablo Fernández Peñas
3 May 2019 Author responded Author comments - Lihu Gu
Resubmission - Version 3
3 May 2019 Submitted Manuscript version 3
29 May 2019 Author responded Author comments - Lihu Gu
Resubmission - Version 4
29 May 2019 Submitted Manuscript version 4
Publishing
31 May 2019 Editorially accepted
10 Jun 2019 Article published 10.1186/s12885-019-5785-z

You can find further information about peer review here.

Back to article page